نتایج جستجو برای: mcf7

تعداد نتایج: 2565  

Journal: :The Analyst 2010
Nihal Simsek Ozek Serkan Tuna A Elif Erson-Bensan Feride Severcan

MicroRNAs (miRNAs), are ~22 nucleotides long, non-coding RNAs that control gene expression post-transcriptionally by binding to their target mRNA's 3'UTRs (untranslated regions). Due to their roles in various important regulatory processes and pathways, miRNAs have been implicated in disease mechanisms such as tumorigenesis when their expression is deregulated. To date, a significant number of ...

Journal: :Carcinogenesis 2006
Annarica Calcabrini José Manuel García-Martínez Lorena González Mercedes Julián Tendero María Teresa Agulló Ortuño Pasqualina Crateri Abelardo Lopez-Rivas Giuseppe Arancia Pedro González-Porqué Jorge Martín-Pérez

Lauryl gallate is an antioxidant food additive showing low toxicity to normal cells. Here, its antiproliferative effect has been studied on three human breast cancer cell lines: estrogen-dependent, wild-type p53, MCF7; estrogen-independent, non-functional p53, MDA-MB-231 and MCF7 ADR, which overexpresses P-glycoprotein (P-gp) and displays a multidrug-resistant phenotype. Lauryl gallate inhibite...

Journal: :Molecular pharmacology 2005
Yang Liu Hui Peng Jian-Ting Zhang

ATP-binding cassette (ABC) membrane proteins comprise a superfamily of transporters with a wide variety of substrates. Humans have 49 members in this superfamily. Several human ABC transporters, such as ABCB1 and ABCC1, have been attributed to cause multidrug resistance (MDR) in cancer treatment when over-expressed. In the past, an MDR cancer cell line MCF7/AdVp3000 has been selected, and overe...

Journal: :Advances in pharmacological sciences 2016
Desak Gede Budi Krisnamurti Melva Louisa Erlia Anggraeni Septelia Inawati Wanandi

Tamoxifen is the first line drug used in the treatment of estrogen receptor-positive (ER+) breast cancer. The development of multidrug resistance (MDR) to tamoxifen remains a major challenge in the treatment of cancer. One of the mechanisms related to MDR is decrease of drug influx via overexpression of drug efflux transporters such as P-glycoprotein (P-gp/MDR1), multidrug resistance associated...

Journal: :Bioinformatics 2003
Benjamin J. Raphael Stanislav Volik Colin Collins Pavel A. Pevzner

Although cancer progression is often associated with genome rearrangements, little is known about the detailed genomic architecture of tumor genomes. The attempt to reconstruct the genomic organization of a tumor genome recently resulted in the development of the End Sequence Profiling (ESP) technique, and the application of this technique to human MCF7 tumor cells. We formulate the ESP Genome ...

2017
Theodossis A. Theodossiou Cathrine E. Olsen Marte Jonsson Andreas Kubin John S. Hothersall Kristian Berg

The diverse responses of different cancers to treatments such as photodynamic therapy of cancer (PDT) have fueled a growing need for reliable predictive markers for treatment outcome. In the present work we have studied the differential response of two phenotypically and genotypically different breast adenocarcinoma cell lines, MCF7 and MDA-MB-231, to hypericin PDT (HYP-PDT). MDA-MB-231 cells w...

2014
Mulyadi Tanjung Tjitjik Srie Tjahjandarie

Three dihydroflavonol derivatives, macarecurvatin A (1), macarecurvatin B (2), and 6,8-diisoprenylaromadendrin (3) have been isolated from the leaves of Macaranga recurvata. The structures of these compounds were determined based on UV, IR, HRESIMS, 1D and 2D NMR data. All of compound isolated were evaluated for their inhibitory effect on scavenging DPPH radical and their growth inhibition on M...

Journal: :iranian journal of basic medical sciences 0
tahereh komeili-movahhed molecular research laboratory, department of pharmacology and toxicology, tehran university of medical sciences, tehran, iran cellular and molecular research center, qom university of medical sciences, qom, iran shamileh fouladdel molecular research laboratory, department of pharmacology and toxicology, tehran university of medical sciences, tehran, iran elmira barzegar molecular research laboratory, department of pharmacology and toxicology, tehran university of medical sciences, tehran, iran shekoufeh atashpour molecular research laboratory, department of pharmacology and toxicology, tehran university of medical sciences, tehran, iran mohammad hossein ghahremani department of pharmacology and toxicology, faculty of pharmacy, tehran university of medical sciences, tehran, iran

objective(s):multidrug resistance (mdr) of cancer cells is a major obstacle to successful chemotherapy. overexpression of breast cancer resistance protein (bcrp) is one of the major causes of mdr. in addition, it has been shown that pi3k/akt signaling pathway involves in drug resistance. therefore, we evaluated the effects of novel approaches including sirna directed against bcrp and targeted t...

Journal: :International journal of oncology 2010
Gregor M Balaburski Rita C Dardes Michael Johnson Bassem Haddad Fang Zhu Eric A Ross Surojeet Sengupta Andres Klein-Szanto Hong Liu Eun Sook Lee Helen Kim V Craig Jordan

We have previously demonstrated that prolonged treatments with raloxifene (RAL) in vitro will result in phase II RAL resistance and RAL-induced tumor growth. Clinical interest prompted us to re-examine RAL resistance in vivo, particularly the effects of long-term treatments (a decade or more) on the evolution of RAL resistance. In this study, we have addressed the question of this being a repro...

Journal: :Malaysian applied biology 2022

Senescence-induced therapy has been improved to increase its cytotoxicity and reduce the resistance of breast cancer cells chemotherapy agents. An example a potential senescence-inducing agent is black cumin oil (BCO) because one major compounds, α-pinene, can induce senescent cells. This study aims explore activity BCO in HER2-overexpressing (MCF7/HER2). The yield obtained from hydro-distillat...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید